ISSN (Print):
1871-5265
ISSN (Online):
2212-3989
Download PDF Flyer

Infectious Disorders - Drug Targets

All Open Access articles of this journal are also available on ScienceDirect.

(Formerly as Current Drug Targets - Infectious Disorders)

Indexed in: Scopus, MEDLINE/PubMed, Cabell's Directory/Journalytics... View all

Volume 26 , Issues 8, 2026


Institutional Members

Aims & Scope

Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders, e.g. disease disease-specific proteins, receptors, enzymes and genes. Each issue of the journal contains a series of timely, in-depth reviews/mini-reviews and research articles written by leaders in the field, covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel drug targets for anti-infective drug discovery continue to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug design, discovery and development. All aspects of the epidemiology, pathogenesis, clinical relevance, theranostics, as well as preventive measures related to infectious disorders caused by bacteria, fungi, parasites, viruses, HIV and other sexually transmitted diseases (STDs) are also included in the scope of the journal.

Infectious Disorders - Drug Targets is an international, peer-reviewed journal on all aspects of drug targets involved in infectious disorders, published bi-monthly (print & online) by Bentham Science Publishers.

Special Offers

30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published. Multiple issue copies at discounted rates.


COPE Compliant
Endorsement(s)

"The rewards of genomics research translated into novel drug discovery using both traditional and innovative approaches will be captured in reviews of interest both to academic and applied infectious disease researches."

John Mekalanos
Harvard Medical School, USA

© 2026 Bentham Science Publishers | Privacy Policy